Your Patients Can't Find Budesonide XR — Here's How to Help

You've written the prescription. Your patient goes to their pharmacy. The pharmacy says it's out of stock. Your patient calls your office, frustrated. Your staff spends 20 minutes on the phone trying to help. Sound familiar?

Budesonide extended-release capsules — used primarily for mild to moderate Crohn's disease — have been intermittently difficult to source since 2023. This guide gives you a practical, step-by-step approach to help your patients find Budesonide XR in stock while minimizing disruption to your practice workflow.

Current Availability: What You Need to Know

As of early 2026, the Budesonide XR supply picture looks like this:

• Generic Budesonide 3 mg extended-release capsules are the most commonly prescribed and the most frequently backordered. Availability varies by region and pharmacy.
• 6 mg and 9 mg capsules tend to be harder to find than the 3 mg strength.
• Brand Entocort EC is rarely stocked at retail pharmacies and is significantly more expensive ($800–$1,200 for a 30-day supply).
• Uceris (extended-release tablets) and Tarpeyo (delayed-release capsules) are available but are not appropriate substitutes for the capsule formulation — they are designed for different conditions and release medication in different GI locations.

For a detailed breakdown of the shortage, see our provider briefing on the Budesonide XR shortage.

Why Patients Can't Find It

Understanding the root causes helps you communicate with patients and set expectations:

1. Manufacturing consolidation: Fewer generic manufacturers are producing Budesonide capsules, reducing supply resilience.
2. Increased prescribing volume: Rising IBD prevalence and expanded off-label use (microscopic colitis, autoimmune hepatitis) have increased demand.
3. Supply chain fragility: Global sourcing of active pharmaceutical ingredients makes production vulnerable to shipping delays and regulatory disruptions.
4. Pharmacy ordering limitations: Chain pharmacies may have restricted wholesaler relationships that limit their ability to source from alternative suppliers.

5 Steps to Help Your Patients Find Budesonide XR

Step 1: Direct Patients to Medfinder

Medfinder for Providers is a free tool that shows real-time pharmacy availability. You or your staff can:

• Check which pharmacies near your patient currently have Budesonide XR in stock
• Provide patients with specific pharmacy names and addresses
• Reduce incoming phone calls by proactively sharing availability information at the point of prescribing

Consider adding medfinder.com/providers to your EHR quick links or sharing the patient-facing site (medfinder.com) in after-visit summaries.

Step 2: Prescribe Flexibly

When writing prescriptions for Budesonide XR, consider these strategies to maximize fillability:

• Prescribe the 3 mg strength with instructions for patients to take three capsules (total 9 mg) rather than prescribing the 9 mg capsule directly. The 3 mg strength is more widely available.
• Include "DAW 0" (Dispense As Written — substitution permitted) to allow pharmacies maximum flexibility in sourcing.
• Send prescriptions electronically so pharmacies can check stock before the patient arrives.
• Consider 90-day prescriptions for stable maintenance patients, which can be filled through mail-order pharmacies with larger inventories.

Step 3: Recommend Independent and Specialty Pharmacies

Independent pharmacies often have more sourcing flexibility than chain pharmacies:

• They may work with multiple wholesalers
• They can place special orders more readily
• Compounding pharmacies can prepare Budesonide capsules if commercial products are unavailable (requires a specific prescription)

If your practice works with a specialty pharmacy for biologics or other GI medications, check whether they also carry Budesonide XR.

Step 4: Have an Alternative Plan Ready

For patients who cannot find Budesonide XR despite best efforts, be prepared to prescribe alternatives:

For active Crohn's disease flares:

• Prednisone 40 mg daily with standard taper — widely available, $4–$10 for a 30-day supply. More systemic side effects than Budesonide.
• Prednisolone — bioactive form of Prednisone, preferred in hepatic impairment. Available as liquid. $10–$30.
• Methylprednisolone — alternative systemic steroid with slightly different dosing profile. $15–$40 (oral).

For maintenance therapy:

• Mesalamine — may be appropriate for mild colonic disease. Limited evidence for Crohn's maintenance specifically.
• Immunomodulators (Azathioprine, 6-MP) — established steroid-sparing maintenance therapy.
• Biologics — consider escalation for patients with frequent flares or steroid dependence.

For a patient-facing overview you can share, see alternatives to Budesonide XR.

Step 5: Proactive Patient Communication

Reduce patient anxiety and phone call volume with proactive communication:

• At the point of prescribing: "This medication has had some supply issues. If your pharmacy doesn't have it, try Medfinder.com to find a pharmacy that does. If you can't find it within a few days, call us and we'll work on an alternative."
• In your patient portal: Post a general notice about Budesonide availability with links to Medfinder and your office contact information.
• For refill patients: Encourage early refills (7–10 days before running out) to allow time for sourcing.

Managing Transitions Safely

When switching patients from Budesonide XR to an alternative corticosteroid, keep these considerations in mind:

• Adrenal suppression risk: Patients on Budesonide XR for more than 2–3 weeks may have some degree of adrenal suppression. Transition to systemic steroids at appropriate equivalent doses, then taper.
• Equivalent dosing: Budesonide 9 mg orally has approximately the same anti-inflammatory effect as Prednisone 20–25 mg, though direct equivalence is approximate due to differences in bioavailability and local vs. systemic action.
• Patient counseling: Advise patients about the increased side effect profile of systemic steroids. Provide clear tapering instructions.

Workflow Tips for Your Practice

• Create a shortage protocol: Document your practice's preferred alternative regimens for Budesonide XR so any provider in your group can manage the situation consistently.
• Train front desk and MA staff: Equip them with the Medfinder link and basic guidance so they can help patients with initial troubleshooting before escalating to the provider.
• Batch prescription modifications: If multiple patients are affected, set aside time to review and modify prescriptions proactively rather than responding to individual emergency calls.
• Monitor the FDA shortage database: Check periodically for updates on Budesonide supply and estimated resolution timelines.

Final Thoughts

The Budesonide XR shortage is a workflow challenge that's unlikely to resolve overnight. But with the right tools and a proactive approach, you can minimize its impact on your patients and your practice.

Start by integrating Medfinder for Providers into your prescribing workflow, prepare alternative regimens in advance, and communicate proactively with your patients about potential supply issues. A few minutes of planning now can prevent hours of reactive problem-solving later.